C86.41

HCC Category Mapping

What This Code Means

This is a rare type of blood cancer involving natural killer cells that are in remission, meaning the cancer is responding to treatment and symptoms have improved. The 'blastic' designation indicates the cancer cells are immature forms.

Coding Tips

• •Ensure documentation clearly states the remission status, as the 5th character '1' specifically indicates remission; other characters would indicate different disease states (active, not in remission, etc.)
• •This code requires a primary malignancy diagnosis and should be used with caution to verify it's not being confused with other NK-cell lymphomas; confirm the specific blastic variant is documented by the oncologist

Clinical Significance

Blastic NK-cell lymphoma in remission represents an uncommon but favorable treatment outcome in this typically aggressive malignancy. Remission is most often achieved through intensive chemotherapy regimens similar to acute leukemia protocols, sometimes followed by stem cell transplantation. Close surveillance is essential due to the high relapse rate, and ongoing monitoring of skin, blood counts, and bone marrow may be required.

Documentation Requirements

• ✓Remission must be explicitly stated by the treating oncologist with supporting evidence from skin examination, blood work, bone marrow biopsy, and imaging studies.
• ✓The original pathologic confirmation of blastic NK-cell lymphoma must be in the medical record.
• ✓Surveillance plan and any transplant-related care must be documented.

Commonly Confused Codes